Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Alpha-lipoic Acid Supplementation on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL)-Double Blind, Randomized, Placebo-controlled Trial

NCT05485259 is registered in ClinicalTrials.gov with University of Zagreb as lead sponsor.

NCT NCT05485259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05485259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Alpha-lipoic Acid Supplementation on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL)-Double Blind, Randomized, Placebo-controlled Trial
Lead sponsor
University of Zagreb
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2020
Completion date
June 15, 2022
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade squamous intraepithelial lesions